The disulfide bonded ring of iso-rANP, unlike that of rANP, has potent cardiovascular activity

Abstract

Iso-atrial natriuretic peptide (iso-rANP), a 45 amino acid peptide with a disulfide bond between residues 23 and 39, is a newly discovered second atrial hormone with considerable homology with rat atrial natriuretic peptide (rANP). We have reported that iso-rANP(1–45) has effects similar to rANP in anesthetized rats in causing hypotension, a decrease in heart rate, and an increase in urine flow and electrolyte excretion. In the present experiments, we found that, unlike the ring peptide of rANP (rANP(105–121)), bolus injections of the ring peptide of iso-rANP (iso-rANP(23–39)) had considerable effects on the circulation but only small effects on the kidney, compared with iso-rANP(1–45). However, the effects of iso-rANP(23–39) in causing hypotension and decreasing heart rate were transient compared with those of iso-rANP(1–45). When we substituted a glycine for arginine into the ring portion of iso-rANP at position 36, so that there were only three amino acids different from the ring of rANP, biological activity of iso-rANP(23–39) was retained. In our bioassay system, all of the circulatory effects and most of the renal effects of rANP are mediated via vagal sensory afferents. We found that the effects of the ring peptide of iso-rANP on the circulation and the kidney were unchanged following vagotomy. The results indicate that iso-rANP(23–39) mediates at least some biological effects by membrane receptor mechanisms different from those of rANP and that the ring portion of iso-rANP probably contributes to nonvagally mediated responses of iso-rANP(1–45).Key words: iso-atrial natriuretic peptide, structure–activity, receptor mechanisms, vagal chemoafferents.